Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gain Therapeutics, Inc. - Common Stock
(NQ:
GANX
)
1.560
-0.010 (-0.64%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gain Therapeutics, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
Small-Cap Gain Therapeutics Stock Falls On Phase 1 Data From Its Lead Asset For Parkinson's Disease
August 29, 2024
Gain Therapeutics reported positive Phase 1 results for GT-02287, showing safety and tolerability across all age groups. The company plans a Parkinson's disease trial by Q4 2024.
Via
Benzinga
GANX Stock Earnings: Gain Therapeutics Misses EPS for Q2 2024
August 08, 2024
GANX stock results show that Gain Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Gain Therapeutics: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!
Via
InvestorPlace
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via
Benzinga
Dear ARM Stock Fans, Mark Your Calendars for June 24
June 14, 2024
Arm stock is up on Friday and is preparing for a catalyst later this month when it replaces Sirius XM on the Nasdaq 100.
Via
InvestorPlace
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Gain Therapeutics (GANX) Stock Down 25% Today?
June 14, 2024
Gain Therapeutics stock is down on Friday after the company priced an $11 million public offering for roughly 7 million shares of GANX.
Via
InvestorPlace
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 14, 2024
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 30, 2024
Via
Benzinga
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q1 2024
May 14, 2024
GANX stock results show that Gain Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
April 02, 2024
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q4 2023
March 26, 2024
GANX stock results show that Gain Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease
March 05, 2024
Gain Therapeutics' GBA1 Parkinson's disease focused GT-02287's mechanism of action, tackling GCase misfolding to enhance lysosomal activity.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 21, 2023
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 20, 2023
Via
Benzinga
These Apple Insiders Are Selling Shares of AAPL Stock
October 04, 2023
Apple stock is on the move Wednesday after several insiders at the company, including CEO Tim Cook, sold shares of AAPL.
Via
InvestorPlace
Why Is Nvni Group (NVNI) Stock Down 8% Today?
October 04, 2023
Nvni Group is seeing shares of NVNI stock fall on Wednesday following the company's debut debut yesterday following a SPAC merger.
Via
InvestorPlace
Why Is Gain Therapeutics (GANX) Stock Moving Today?
October 04, 2023
Gain Therapeutics stock is on the move Wednesday as investors in GANX react to updated clinical trial news from the company.
Via
InvestorPlace
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.